These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7697956)

  • 1. Clinically silent inflammatory gut lesions in undifferentiated spondyloarthropathies.
    Altomonte L; Zoli A; Veneziani A; Mirone L; Santacesaria G; Chiarelli C; Federico F; Massi G; Magaro M
    Clin Rheumatol; 1994 Dec; 13(4):565-70. PubMed ID: 7697956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut and spondyloarthropathies.
    Leirisalo-Repo M; Repo H
    Rheum Dis Clin North Am; 1992 Feb; 18(1):23-35. PubMed ID: 1561404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Gyselbrecht L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2279-84. PubMed ID: 8835562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin containing cells in terminal ileum and colorectum of patients with arthritis related gut inflammation.
    Cuvelier C; Mielants H; De Vos M; Veys E; Roels H
    Gut; 1988 Jul; 29(7):916-25. PubMed ID: 3396965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects.
    Mielants H; Veys EM; De Vos M; Cuvelier C; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2266-72. PubMed ID: 8835560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical involvement of the gut in undifferentiated spondylarthropathies.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Clin Exp Rheumatol; 1989; 7(5):499-504. PubMed ID: 2591124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study.
    Mielants H; Veys EM; Goemaere S; Goethals K; Cuvelier C; De Vos M
    J Rheumatol; 1991 Oct; 18(10):1542-51. PubMed ID: 1765980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease.
    Cooper R; Fraser SM; Sturrock RD; Gemmell CG
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1432-4. PubMed ID: 3132277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.
    Hoffman IE; Demetter P; Peeters M; De Vos M; Mielants H; Veys EM; De Keyser F
    Ann Rheum Dis; 2003 May; 62(5):455-9. PubMed ID: 12695160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of gut inflammation in the pathogenesis of spondyloarthropathies.
    Mielants H; De Vos M; Cuvelier C; Veys EM
    Acta Clin Belg; 1996; 51(5):340-9. PubMed ID: 8950841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of the seronegative spondyloarthropathies with sulfasalazine.
    Zwillich SH; Comer SS; Lee E; Erdman WA; Lipsky PE
    J Rheumatol Suppl; 1988 Sep; 16():33-9. PubMed ID: 2903925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
    Mielants H; Veys EM
    Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal lesions associated with spondyloarthropathies.
    Orlando A; Renna S; Perricone G; Cottone M
    World J Gastroenterol; 2009 May; 15(20):2443-8. PubMed ID: 19468992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating axial manifestations in ankylosing spondylitis in the presence of peripheral arthritis.
    Lee W; Weisman MH
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):298-9. PubMed ID: 16932706
    [No Abstract]   [Full Text] [Related]  

  • 17. High frequency of silent inflammatory bowel disease in spondylarthropathy.
    Leirisalo-Repo M; Turunen U; Stenman S; Helenius P; Seppälä K
    Arthritis Rheum; 1994 Jan; 37(1):23-31. PubMed ID: 8129761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-TNF-alpha treatment and spondyloarthropathies].
    Braun Y; Balbir-Gurman A
    Harefuah; 2002 Nov; 141(11):965-8, 1010. PubMed ID: 12476631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment.
    Fragoulis GE; Liava C; Daoussis D; Akriviadis E; Garyfallos A; Dimitroulas T
    World J Gastroenterol; 2019 May; 25(18):2162-2176. PubMed ID: 31143068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease.
    O'Mahony S; Anderson N; Nuki G; Ferguson A
    Ann Rheum Dis; 1992 Dec; 51(12):1296-300. PubMed ID: 1485810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.